Data / Drug companies / Bimatoprost
Bimatoprost: 15 companies and 28 products in the FDA NDC directory
Bimatoprost is listed in the FDA National Drug Code Directory by 15 companies, with 28 products in commercial distribution. 24 of the products (85.7%) are marketed under an abbreviated new drug application (ANDA), the generic route. The most common dosage forms are solution/ drops; implant; gel, and the newest product started marketing on May 1, 2026.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Companies listing it
- 15
- Products
- 28
- Generic (ANDA) products
- 24 (85.7%)
- Application numbers
- 14
- Routes
- Ophthalmic, Intracameral
- Brand names
- Lumigan, Durysta, Latisse, Zolymbus
- openFDA record search
- api.fda.gov
Companies that list bimatoprost
Ranked by number of products. Finished drugs in commercial distribution.
| Company | Products | Main dosage forms | Main marketing category | Newest product started |
|---|---|---|---|---|
| Allergan, Inc. | 3 | solution/ drops; implant | New drug applications (NDA) | March 4, 2020 |
| Fosun Pharma USA Inc. | 3 | solution/ drops | Generic drugs (ANDA) | November 30, 2025 |
| Gland Pharma Limited | 3 | solution/ drops | Generic drugs (ANDA) | August 12, 2020 |
| Lifestar Pharma LLC | 3 | solution/ drops | Generic drugs (ANDA) | March 17, 2026 |
| Somerset Therapeutics, LLC | 3 | solution/ drops | Generic drugs (ANDA) | June 19, 2019 |
| Alembic Pharmaceuticals Inc. | 2 | solution/ drops | Generic drugs (ANDA) | January 21, 2020 |
| Alembic Pharmaceuticals Limited | 2 | solution/ drops | Generic drugs (ANDA) | July 21, 2023 |
| NuCare Pharmaceuticals,Inc. | 2 | solution/ drops | Generic drugs (ANDA) | March 15, 2021 |
| Amneal Pharmaceuticals NY LLC | 1 | solution/ drops | Generic drugs (ANDA) | September 22, 2025 |
| Apotex Corp. | 1 | solution/ drops | Generic drugs (ANDA) | October 8, 2018 |
| Aurobindo Pharma Limited | 1 | solution/ drops | Generic drugs (ANDA) | October 6, 2022 |
| First Nation Group, LLC | 1 | solution/ drops | Generic drugs (ANDA) | May 1, 2026 |
| Micro Labs Limited | 1 | solution/ drops | Generic drugs (ANDA) | March 15, 2021 |
| Sandoz Inc | 1 | solution/ drops | Generic drugs (ANDA) | December 6, 2016 |
| Thea Pharma Inc. | 1 | gel | New drug applications (NDA) | February 26, 2026 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Solution/ drops | 26 | 92.9% |
| Implant | 1 | 3.6% |
| Gel | 1 | 3.6% |
Marketing categories
| Marketing category | Products | Share |
|---|---|---|
| Generic drugs (ANDA) | 24 | 85.7% |
| New drug applications (NDA) | 4 | 14.3% |
Pharmacologic classes
| Class | Products |
|---|---|
| Prostaglandin Analog | 28 |
Updated November 6, 2026. Read from US Food and Drug Administration, National Drug Code Directory (openFDA). CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.